PULMONX CORPORATION Foreign Currency Transaction Gain (Loss), Realized
PULMONX CORPORATION (LUNG) reported Foreign Currency Transaction Gain (Loss), Realized of -$100.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2026-08-04
- PULMONX CORPORATION foreign currency transaction gain (loss), realized for the quarter ending 2026-06-30 was -$100.00K.
- PULMONX CORPORATION foreign currency transaction gain (loss), realized for the quarter ending 2026-03-31 was -$200.00K, a 300.00% decline year-over-year.
- PULMONX CORPORATION foreign currency transaction gain (loss), realized for the quarter ending 2025-12-31 was -$100.00K.
- PULMONX CORPORATION foreign currency transaction gain (loss), realized for the quarter ending 2025-09-30 was $800.00K.
- PULMONX CORPORATION foreign currency transaction gain (loss), realized for fiscal 2025 was $700.00K, a 600.00% increase from fiscal 2024.
- PULMONX CORPORATION foreign currency transaction gain (loss), realized for fiscal 2024 was $100.00K.
- PULMONX CORPORATION foreign currency transaction gain (loss), realized for fiscal 2023 was -$800.00K.
- PULMONX CORPORATION foreign currency transaction gain (loss), realized for fiscal 2022 was -$400.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Realized 3 month | Foreign Currency Transaction Gain (Loss), Realized 3 month as first filed | Foreign Currency Transaction Gain (Loss), Realized 6 month | Foreign Currency Transaction Gain (Loss), Realized 9 month | Foreign Currency Transaction Gain (Loss), Realized 9 month as first filed | Foreign Currency Transaction Gain (Loss), Realized 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$100.00K 10-Q · filed 2026-08-04 | -$200.00K 10-Q · filed 2026-08-04 | -$400.00K derived: sum of 3 quarters · filed 2026-08-04 | $400.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-03-31 | -$200.00K 10-Q · filed 2026-05-04 | -$300.00K derived: sum of 2 quarters · filed 2026-05-04 | $500.00K derived: sum of 3 quarters · filed 2026-05-04 | $400.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $700.00K derived: sum of 2 quarters · filed 2026-03-10 | $600.00K derived: sum of 3 quarters · filed 2026-08-04 | $700.00K 10-K · filed 2026-03-10 | ||
| 2025-09-30 | $800.00K 10-Q · filed 2025-11-12 | $700.00K derived: sum of 2 quarters · filed 2026-08-04 | $800.00K 10-Q · filed 2025-11-12 | $800.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-06-30 | -$100.00K 10-Q · filed 2026-08-04 | $100.00K 10-Q · filed 2026-08-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | -$200.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $100.00K 10-Q · filed 2026-05-04 | $100.00K derived: sum of 2 quarters · filed 2026-05-04 | -$100.00K derived: sum of 3 quarters · filed 2026-05-04 | -$200.00K derived: sum of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$200.00K derived: sum of 2 quarters · filed 2026-03-10 | -$300.00K derived: sum of 3 quarters · filed 2026-03-10 | $100.00K 10-K · filed 2026-03-10 | ||
| 2024-09-30 | -$200.00K 10-Q · filed 2025-11-12 | -$300.00K derived: sum of 2 quarters · filed 2025-11-12 | $100.00K 10-Q · filed 2025-11-12 | -$300.00K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | -$100.00K 10-Q · filed 2025-08-01 | $300.00K 10-Q · filed 2025-08-01 | -$100.00K derived: sum of 3 quarters · filed 2025-08-01 | -$400.00K derived: sum of 4 quarters · filed 2025-08-01 | ||
| 2024-03-31 | $400.00K 10-Q · filed 2025-05-02 | $0.00 derived: sum of 2 quarters · filed 2025-05-02 | -$300.00K derived: sum of 3 quarters · filed 2025-05-02 | -$500.00K derived: sum of 4 quarters · filed 2025-05-02 | ||
| 2023-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$700.00K derived: sum of 2 quarters · filed 2025-02-25 | -$900.00K derived: sum of 3 quarters · filed 2025-02-25 | -$800.00K 10-K · filed 2025-02-25 | ||
| 2023-09-30 | -$300.00K 10-Q · filed 2024-11-01 | -$500.00K derived: sum of 2 quarters · filed 2024-11-01 | -$400.00K 10-Q · filed 2024-11-01 | -$200.00K derived: sum of 4 quarters · filed 2024-11-01 | ||
| 2023-06-30 | -$200.00K 10-Q · filed 2024-08-02 | -$200.00K 10-Q · filed 2024-08-02 | $100.00K derived: sum of 3 quarters · filed 2024-08-02 | -$300.00K derived: sum of 4 quarters · filed 2024-08-02 | ||
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-03 | $300.00K derived: sum of 2 quarters · filed 2024-05-03 | -$100.00K derived: sum of 3 quarters · filed 2024-05-03 | -$300.00K derived: sum of 4 quarters · filed 2024-05-03 | ||
| 2022-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$200.00K derived: sum of 2 quarters · filed 2024-02-27 | -$400.00K derived: sum of 3 quarters · filed 2024-02-27 | -$400.00K 10-K · filed 2024-02-27 | ||
| 2022-09-30 | -$400.00K 10-Q · filed 2023-11-03 | -$600.00K derived: sum of 2 quarters · filed 2023-11-03 | -$600.00K 10-Q · filed 2023-11-03 | -$1.10M derived: sum of 4 quarters · filed 2023-11-03 | ||
| 2022-06-30 | -$200.00K 10-Q · filed 2023-08-04 | -$200.00K 10-Q · filed 2023-08-04 | -$700.00K derived: sum of 3 quarters · filed 2023-08-04 | -$1.00M derived: sum of 4 quarters · filed 2023-08-04 | ||
| 2022-03-31 | -$100.00K 10-Q · filed 2023-05-08 | -$500.00K derived: sum of 2 quarters · filed 2023-05-08 | -$800.00K derived: sum of 3 quarters · filed 2023-05-08 | -$900.00K derived: sum of 4 quarters · filed 2023-05-08 | ||
| 2021-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$700.00K derived: sum of 2 quarters · filed 2023-03-01 | -$800.00K derived: sum of 3 quarters · filed 2023-03-01 | -$600.00K 10-K · filed 2023-03-01 | ||
| 2021-09-30 | -$300.00K 10-Q · filed 2022-11-08 | -$400.00K derived: sum of 2 quarters · filed 2022-11-08 | -$200.00K 10-Q · filed 2022-11-08 | $100.00K derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | -$100.00K 10-Q · filed 2022-08-08 | $100.00K 10-Q · filed 2022-08-08 | $400.00K derived: sum of 3 quarters · filed 2022-08-08 | $500.00K derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | $200.00K 10-Q · filed 2022-05-09 | $500.00K derived: sum of 2 quarters · filed 2022-05-09 | $600.00K derived: sum of 3 quarters · filed 2022-05-09 | $800.00K derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $400.00K derived: sum of 2 quarters · filed 2022-03-01 | $600.00K derived: sum of 3 quarters · filed 2022-03-01 | $100.00K 10-K · filed 2022-03-01 | ||
| 2020-09-30 | $100.00K 10-Q · filed 2021-11-09 | -$100.00K 10-Q · filed 2020-11-13 | $300.00K derived: sum of 2 quarters · filed 2021-11-09 | -$200.00K 10-Q · filed 2021-11-09 | $200.00K 10-Q · filed 2020-11-13 | -$700.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $200.00K 10-Q · filed 2021-08-10 | -$300.00K 10-Q · filed 2021-08-10 | -$800.00K derived: sum of 3 quarters · filed 2021-08-10 | -$600.00K derived: sum of 4 quarters · filed 2021-08-10 | ||
| 2020-03-31 | -$500.00K 10-Q · filed 2021-05-12 | -$1.00M derived: sum of 2 quarters · filed 2021-05-12 | -$800.00K derived: sum of 3 quarters · filed 2021-05-12 | |||
| 2019-12-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$300.00K derived: sum of 2 quarters · filed 2021-03-15 | -$100.00K 10-K · filed 2021-03-15 | |||
| 2019-09-30 | $200.00K 10-Q · filed 2020-11-13 | $400.00K 10-Q · filed 2020-11-13 | ||||
| 2018-12-31 | -$300.00K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |